Vanderbilt University Medical Center (VUMC) is committed to excellence in patient care, leadership in research, and preeminence in medical education. Our culture thrives on challenges and champions innovation, while striving to make healthcare personal.
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma
This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Read More
Pharmacists Are Essential in Managing Transitions of Care for Patients
June 16th 2022Aimee Banks, PharmD, BCPS, MSCS, clinical pharmacist in the Multiple Sclerosis Clinic at Vanderbilt University Medical Center, discusses the role of the pharmacists in patient care, improving outcomes, and managing transitions of care.
Watch
Expert Discusses What Pharmacists Need to Know About Encorafeni, Binimetinib
June 14th 2022Brooke Looney, PharmD, certified specialty pharmacist in the Oncology Clinic at Vanderbilt Specialty Pharmacy, discusses medication changes and adverse events for patients starting encorafenib and binimetinib.
Watch
Expert Discusses New Specialty Drugs That are in the Pipeline
June 12th 2022Aimee Banks, PharmD, BCPS, MSCS, clinical pharmacist in the Multiple Sclerosis Clinic at Vanderbilt University Medical Center, discusses new hematology, oncology, and autoimmune therapies in the pipeline that pharmacists should be aware of.
Watch
How Health Systems Can Address the National Blood Shortage, Increase Blood Donations
November 8th 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what health systems can do to address the national blood shortage and increase blood donations.
Watch
How the National Blood Shortage May Impact Patient Care, Outcomes
October 21st 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses how a national blood shortage could affect patient care and outcomes.
Watch
Navigating the Patient Journey in Specialty Pharmacy
May 19th 2020Autumn Zuckerman, director of specialty pharmacy at Vanderbilt University Medical Center, and JoAnn Stubbings, a professor at the University of Illinois at Chicago College of Pharmacy, discuss the role of specialty pharmacists in guiding patients throughout their journey.
Watch
Vanderbilt University and Bristol-Myers Squibb Company announced that they have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators or PAMs, for the treatment of Parkinson's disease.
Read More